A/H1N1 pandemic: Oseltamivir's adverse events

BMJ (Online)

Volumn 339, Issue 7717, 2009, Pages 359-

  Strong, Mark ^c   Burrows, Julia ^a   Redgrave, Paul ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; ANTIVIRUS AGENT;

ABDOMINAL PAIN; ADVERSE DRUG REACTION; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; LETTER; MAJOR CLINICAL STUDY; MENTAL DISEASE; NAUSEA; PANDEMIC; PRIORITY JOURNAL; TREATMENT DURATION; VOMITING;

ANTIVIRAL AGENTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; OSELTAMIVIR;

EID: 69449099839     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b3249     Document Type: Letter

References (1)

1. O'Dowd A. A/H1N1 influenza update. BMJ 2009;339:b2977. (23 July.)[CrossRef][Medline]